Our Non-Proprietary Assays repository includes a wide range of LC/MS bioanalytical methods that have already been developed, fully validated and are available for immediate use in your projects. This approach helps pharmaceutical and biotechnology companies accelerate development timelines while benefiting from reliable, regulatory-ready analytical solutions.
These methods cover a broad range of small molecules (both innovative and generic) and large molecules such as peptides, oligonucleotides, lipids, and proteins, as well as biomarkers including comprehensive steroid panels.
Skip the development and validation phase. Our methods are ready to deploy, helping you meet aggressive timelines
Minimize project budgets by leveraging existing validated assays
All methods are GLP-compliant, validated following ICH M10 and regulatory authority requirements
Applicable to diverse therapeutic areas and study types
Ready for use in PK/TK, bioequivalence, biodistribution, and biomarker studies
01
Innovative small molecules — various therapeutic classes
02
Generic drug APIs — multiple bioequivalence-ready assays
03
Peptides and peptide hormones
04
Oligonucleotides (including GalNAc conjugates)
05
Lipids and lipid mediators
06
Proteins and protein fragments
07
Steroid biomarker panels
Explore our non-proprietary LC/MS methods and start your project with proven, regulatory-ready assays.
